EP3641634A2 - System and method for noninvasive analysis of subcutaneous tissue - Google Patents
System and method for noninvasive analysis of subcutaneous tissueInfo
- Publication number
- EP3641634A2 EP3641634A2 EP18820207.1A EP18820207A EP3641634A2 EP 3641634 A2 EP3641634 A2 EP 3641634A2 EP 18820207 A EP18820207 A EP 18820207A EP 3641634 A2 EP3641634 A2 EP 3641634A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- radiation
- tissue
- spectral
- absorption
- detector
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 43
- 238000004458 analytical method Methods 0.000 title claims abstract description 36
- 206010033675 panniculitis Diseases 0.000 title abstract description 6
- 210000004304 subcutaneous tissue Anatomy 0.000 title abstract description 6
- 230000005855 radiation Effects 0.000 claims abstract description 347
- 230000003595 spectral effect Effects 0.000 claims abstract description 166
- 238000010521 absorption reaction Methods 0.000 claims abstract description 84
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 45
- 230000003993 interaction Effects 0.000 claims abstract description 11
- 230000001678 irradiating effect Effects 0.000 claims abstract description 9
- 239000000126 substance Substances 0.000 claims description 49
- 239000007788 liquid Substances 0.000 claims description 35
- 210000004369 blood Anatomy 0.000 claims description 28
- 239000008280 blood Substances 0.000 claims description 28
- 238000007920 subcutaneous administration Methods 0.000 claims description 25
- 208000037816 tissue injury Diseases 0.000 claims description 24
- 230000008859 change Effects 0.000 claims description 15
- 208000004210 Pressure Ulcer Diseases 0.000 claims description 11
- 206010061218 Inflammation Diseases 0.000 claims description 4
- 230000004054 inflammatory process Effects 0.000 claims description 4
- 238000003825 pressing Methods 0.000 claims description 2
- 210000001519 tissue Anatomy 0.000 abstract description 190
- 238000005259 measurement Methods 0.000 description 106
- 230000009102 absorption Effects 0.000 description 70
- 239000000306 component Substances 0.000 description 59
- 230000005540 biological transmission Effects 0.000 description 37
- 238000001514 detection method Methods 0.000 description 28
- 238000002835 absorbance Methods 0.000 description 25
- 230000003287 optical effect Effects 0.000 description 24
- 230000007246 mechanism Effects 0.000 description 22
- 238000012545 processing Methods 0.000 description 19
- 238000001069 Raman spectroscopy Methods 0.000 description 14
- 230000001681 protective effect Effects 0.000 description 11
- 230000005284 excitation Effects 0.000 description 10
- 230000015654 memory Effects 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- 238000013500 data storage Methods 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 238000002834 transmittance Methods 0.000 description 7
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 6
- 208000025865 Ulcer Diseases 0.000 description 6
- 238000009825 accumulation Methods 0.000 description 5
- 230000005670 electromagnetic radiation Effects 0.000 description 5
- 231100000397 ulcer Toxicity 0.000 description 5
- 206010011985 Decubitus ulcer Diseases 0.000 description 4
- 238000003841 Raman measurement Methods 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000035515 penetration Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 102000001554 Hemoglobins Human genes 0.000 description 3
- 108010054147 Hemoglobins Proteins 0.000 description 3
- 102000036675 Myoglobin Human genes 0.000 description 3
- 108010062374 Myoglobin Proteins 0.000 description 3
- 206010033078 Otitis media Diseases 0.000 description 3
- 210000000459 calcaneus Anatomy 0.000 description 3
- 230000004069 differentiation Effects 0.000 description 3
- 210000000883 ear external Anatomy 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 235000021588 free fatty acids Nutrition 0.000 description 3
- 238000001802 infusion Methods 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 239000013307 optical fiber Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 150000003626 triacylglycerols Chemical class 0.000 description 3
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 3
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 108010062497 VLDL Lipoproteins Proteins 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 238000011545 laboratory measurement Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 230000010355 oscillation Effects 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 230000002459 sustained effect Effects 0.000 description 2
- 229920002725 thermoplastic elastomer Polymers 0.000 description 2
- 210000003454 tympanic membrane Anatomy 0.000 description 2
- 102000018832 Cytochromes Human genes 0.000 description 1
- 108010052832 Cytochromes Proteins 0.000 description 1
- 229910000530 Gallium indium arsenide Inorganic materials 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 238000011481 absorbance measurement Methods 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000005465 channeling Effects 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005428 food component Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000005283 ground state Effects 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000002803 maceration Methods 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- OLBCVFGFOZPWHH-UHFFFAOYSA-N propofol Chemical compound CC(C)C1=CC=CC(C(C)C)=C1O OLBCVFGFOZPWHH-UHFFFAOYSA-N 0.000 description 1
- 229960004134 propofol Drugs 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 229910052724 xenon Inorganic materials 0.000 description 1
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0048—Detecting, measuring or recording by applying mechanical forces or stimuli
- A61B5/0053—Detecting, measuring or recording by applying mechanical forces or stimuli by applying pressure, e.g. compression, indentation, palpation, grasping, gauging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/44—Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
- A61B5/441—Skin evaluation, e.g. for skin disorder diagnosis
- A61B5/445—Evaluating skin irritation or skin trauma, e.g. rash, eczema, wound, bed sore
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/44—Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
- A61B5/441—Skin evaluation, e.g. for skin disorder diagnosis
- A61B5/447—Skin evaluation, e.g. for skin disorder diagnosis specially adapted for aiding the prevention of ulcer or pressure sore development, i.e. before the ulcer or sore has developed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/45—For evaluating or diagnosing the musculoskeletal system or teeth
- A61B5/4519—Muscles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4869—Determining body composition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2505/00—Evaluating, monitoring or diagnosing in the context of a particular type of medical care
- A61B2505/01—Emergency care
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2505/00—Evaluating, monitoring or diagnosing in the context of a particular type of medical care
- A61B2505/03—Intensive care
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/02—Details of sensors specially adapted for in-vivo measurements
- A61B2562/0233—Special features of optical sensors or probes classified in A61B5/00
Definitions
- the present invention relates to noninvasive analysis. More particularly, the present invention relates to a system and method for noninvasive analysis of subcutaneous tissue.
- Various medical conditions are characterized by accumulation of liquids under or behind the skin surface. Such conditions may include otitis media, pressure ulcers, or other types of deep tissue injury under intact skin.
- Medications or other substances may be introduced or delivered into the bloodstream.
- a substance may be delivered orally to a patient, or may be injected into tissue or via an intravenous infusion.
- a method for noninvasive analysis of tissue including: irradiating a surface of the tissue with short wave infrared (SWIR) radiation in a first spectral band that is strongly absorbed by water, and with SWIR radiation in a second spectral band such that an interaction of the radiation in both spectral bands with a component of the tissue other than water is substantially identical; measuring an intensity of the radiation that emerges from the tissue in each of the spectral bands; calculating a relative absorption by the tissue of radiation in one of spectral bands relative to absorption by the tissue of radiation in the other of the spectral bands; and determining a state of the tissue in accordance with the calculated relative absorption.
- SWIR short wave infrared
- the first spectral band is in the wavelength range of 1400 nm to 1500 nm.
- the second spectral band is in the wavelength range of 1000 nm to 1350 nm or 1500 nm to 2100 nm.
- a gap in wavelength between the first and second spectral bands is less than 200 nm.
- measuring the intensity includes measuring the intensity of the radiation that is transmitted across the tissue (e.g., passing through the tissue and not reflected back towards the radiation source).
- the tissue includes tissue of a finger or an ear.
- measuring the intensity includes measuring the intensity of the radiation that is reflected by the tissue.
- measuring the intensity includes measuring the intensity of the radiation that emerges from the tissue at a plurality of lateral distances from a location of the irradiating of the tissue.
- the state of the tissue includes a concentration of a substance in blood.
- the substance is an introduced substance.
- a system for noninvasive analysis of tissue including: at least one source of infrared radiation to irradiate the tissue, the infrared radiation including SWIR radiation in a first spectral band that is strongly absorbed by water, and including radiation in a second spectral band such that an interaction of the radiation in both spectral bands with a component of the tissue other than water is substantially identical; at least one radiation detector to measure an intensity of radiation in each of the two spectral bands that emerges from the tissue(e.g., reflected from the tissue or passing through the tissue, to come out at another side); and a processor that is configured to calculate a relative absorption by the tissue of radiation in one of spectral bands relative to absorption by the tissue of radiation in the other of the spectral bands and determine a state of the tissue in accordance with the calculated relative absorption.
- the at least one radiation detector is configured to measure the intensity of the radiation that emerges from a surface of the tissue that is irradiated by the at least one radiation source.
- the at least one radiation detector is configured to measure the intensity of the radiation that emerges from the surface of the tissue at a plurality of lateral distances from the at least one radiation source.
- the at least one radiation detector comprises a plurality of radiation detectors separated by different lateral distances from the at least one radiation source.
- the at least one radiation detector is configured to measure the radiation that emerges from a surface of the tissue that is substantially opposite a surface of the tissue that is irradiated by the at least one radiation source.
- the system includes a removable cover for placement over an aperture of the at least one radiation source or of the at least one radiation detector.
- the at least one radiation source includes two radiation sources, one of the sources being configured to emit radiation in the first spectral band and the other being configured to emit radiation in the second spectral band.
- the at least one radiation detector includes two radiation detectors, one of the detectors being configured to measure an intensity of radiation in the first spectral band and the other being configured to measure an intensity of radiation in the second spectral band.
- the system includes a dispersive element to separate spectral components of the infrared radiation and a micro- mirror array, the micro-mirror array being operable to direct a selected spectral component of the infrared radiation to the tissue or to the at least one radiation detector.
- the first spectral band is in the wavelength range of 1400 nm to 1500 nm.
- the second spectral band is in the wavelength range of 1000 nm to 1350 nm or 1500 nm to 2100 nm.
- a method for determining a state of tissue including: irradiating a surface of the tissue with SWIR radiation in a first spectral band in the wavelength range 1300 nm to 1430 nm, and with SWIR radiation in a second spectral band such that an interaction of the radiation in both spectral bands with a component of the tissue other than water is substantially identical; measuring an intensity of the radiation that emerges from the tissue in each of the spectral bands; and calculating an absorption by the tissue of radiation in the two spectral bands, the absorption being indicative of the state of the tissue.
- FIG. 1 A is a schematic drawing of a system for noninvasive analysis of subcutaneous liquids based on reflection of infrared radiation, in accordance with an embodiment of the present invention.
- Fig. IB is a schematic illustration of a plurality of component apertures of an optical head of the system shown in Fig. 1 A.
- FIG. 2A is a schematic drawing of a measurement unit of a system for noninvasive analysis of subcutaneous liquids based on transmission of infrared radiation, in accordance with an embodiment of the present invention.
- FIG. 2B schematically illustrates attachment of the measurement unit of Fig. 2A to a finger.
- FIG. 2C schematically illustrates attachment of the measurement unit of Fig. 2A to an ear.
- Fig. 3 shows an example of a graph of spectral reflectance.
- Fig. 4 shows a graph of an example of a relationship of absorbance to concentration of a substance.
- FIG. 5 is a flowchart depicting a method for noninvasive analysis of subcutaneous liquids, in accordance with an embodiment of the present invention.
- FIG. 6A schematically illustrates a system for measurement of reflection at a distance from a radiation source, in accordance with an embodiment of the present invention.
- Fig. 6B schematically illustrates an arrangement of a measurement head for concurrent measurement of radiation that emerges from a surface at different lateral distances from the radiation source, in accordance with an embodiment of the present invention.
- FIG. 7 schematically illustrates paths of incident radiation to different detector locations, in accordance with an embodiment of the present invention.
- the terms “plurality” and “a plurality” as used herein may include, for example, “multiple” or “two or more”.
- the terms “plurality” or “a plurality” may be used throughout the specification to describe two or more components, devices, elements, units, parameters, or the like.
- the method embodiments described herein are not constrained to a particular order or sequence. Additionally, some of the described method embodiments or elements thereof can occur or be performed simultaneously, at the same point in time, or concurrently. Unless otherwise indicated, us of the conjunction "or” as used herein is to be understood as inclusive (any or all of the stated options).
- Some embodiments of the invention may include an article such as a computer or processor readable medium, or a computer or processor non-transitory storage medium, such as for example a memory, a disk drive, or a USB flash memory, encoding, including or storing instructions, e.g., computer-executable instructions, which when executed by a processor or controller, carry out methods disclosed herein.
- an article such as a computer or processor readable medium, or a computer or processor non-transitory storage medium, such as for example a memory, a disk drive, or a USB flash memory, encoding, including or storing instructions, e.g., computer-executable instructions, which when executed by a processor or controller, carry out methods disclosed herein.
- reflected radiation may refer to radiation that emerges from the tissue via a surface through which the tissue was irradiated or illuminated.
- reflected radiation may result from one or more of radiation that is reflected from an interface between dissimilar media and radiation that is scattered in the backward direction.
- a measurement unit may be placed on or near a surface of the tissue, e.g., a skin surface of the patient's body, an eardrum, or another surface.
- the measurement unit may include one or more radiation sources and one or more radiation detectors.
- the measurement unit may be configured to measure reflection.
- the radiation sources may be configured to irradiate or illuminate a tissue surface (e.g., a skin surface of a patient). When irradiating the tissue surface, the radiation penetrates into the tissue.
- the radiation detectors may be aimed at the irradiated surface so as to detect radiation that is reflected or backscattered by the tissue that is covered by the surface.
- the radiation sources and detectors may be configured to measure transmission of the radiation through the tissue.
- measurement unit may be configured such that radiation that is emitted by the radiation sources is directed toward the radiation detectors.
- tissue e.g., a part of the patient's body such as an ear, finger, toe, fold of skin, or other part of the body
- transmission of the radiation through the tissue may be measured.
- the reflection or transmission measurement may be indicative of a state of the tissue.
- the tissue may include subcutaneous liquids such as blood or other fluids.
- the term "subcutaneous”, may refer to a depth within tissue, which may or may not be covered with skin.
- subcutaneous liquid may be within or behind a membrane, such as within or behind the eardrum, or within lung tissue.
- the state of the tissue may be indicative of a medical condition in the patient.
- a medical condition may include otitis media, early stages of pressure ulcers, or other types of deep tissue injury under intact skin in which liquids accumulate subcutaneously.
- a state of the tissue may include a concentration of a substance in the blood or other subcutaneous fluids.
- the substance e.g., a medication, contrast agent, food component or supplement, or other administered product
- may have been administered to the patient e.g., orally, or via injection or infusion
- the most common pressure ulcers are above the heel bone under the skin.
- the heel bone is covered with a thin fatty layer which is normally composed of triglycerides. When ischemia starts the triglycerides fatty tissue decomposes into glycerol and free fatty acids .
- a lookup table containing different concentrations of, for example, glycerol and free fatty acids may be created, and may further include data regarding such substances absorption (e.g., in different waivelenghes).
- a processor may determine state of the tissue above the heel bone (or at any other location) by comparing the optical readings from the examined tissue, to the absorption values in the lookup table, and based on the determined concentration of the different substances, determine the existence and degree or severity of DTI.
- the reflection or transmission is measured in at least two spectral bands of the shortwave infrared (SWIR) spectral region of the electromagnetic spectrum.
- SWIR shortwave infrared
- the SWIR spectral region is used to include the wavelength range of about 1000 nm to about 2500 nm. The shorter wavelengths of this spectral region are sometimes referred to as near infrared (NIR).
- a first spectral band may be in a portion of the SWIR spectral region where radiation is strongly absorbed by water (e.g., in the wavelength band from about 1400 nm to about 1500 nm) as compared to adjacent or other bands.
- radiation is considered to by strongly absorbed when absorption (e.g., as characterized by an absorption coefficient) is at least an order of magnitude (approximately 10 times or more) greater than in the comparison band.
- a second spectral band is in an adjacent SWIR spectral band, e.g., in the wavelength band from about 1000 nm to about 1350 nm, or in the wavelength band from about (e.g., ⁇ 10%) 1500 nm to about 2100 nm.
- the second spectral band is sufficiently close to the first spectral band such that an interaction of radiation in both spectral bands (e.g., absorption or scattering) with tissue components other than water is substantially identical (e.g., having the same or very similar behaviorinteraction with the tissue).
- absorption of radiation in the spectral band of about 1000 nm to about 1800 nm by such tissue components other than water such as hemoglobin, melanin, and other chromophores is approximately constant (with absorption coefficients in the range of about 0.1 cm “1 to about 1 cm “1 ).
- the scattering coefficient is about 5 cm “1 to about 15 cm “1 .
- radiation may penetrate as deep as 8 cm to 10 cm into tissue.
- a gap between the two bands may be no more than 200 nm. In some cases, the gap between the two bands may be no more than 100 nm.
- two or more of the radiation sources may be configured to emit radiation in different spectral bands of the SWIR spectral region.
- two or more of the radiation detectors may be configured to detect different radiation in different spectral bands of the SWIR spectral region and/or the visible spectral region (also referred to as VIS). Both the radiation sources and the radiation detectors may be limited to particular spectral bands.
- the source or detector may include a wavelength selection arrangement that incorporates a spectrally dispersive element (e.g., a grating, prism, or spectrally selective optical coating), focusing optics (e.g., lenses or mirrors), and a micro-mirror array that contains individually rotatable micro-mirrors (or rotatable in groups).
- a spectrally dispersive element e.g., a grating, prism, or spectrally selective optical coating
- focusing optics e.g., lenses or mirrors
- micro-mirror array that contains individually rotatable micro-mirrors (or rotatable in groups).
- Radiation originating from the radiation source (for irradiating the tissue) or from the tissue (e.g., after reflection or transmission) may be focused onto the dispersive element to spatially separate different spectral components (e.g., wavelength ranges or spectral bands) of the radiation. For example, different wavelengths of
- Spectrally separated radiation from the dispersive element may be focused onto the micro-mirror array.
- each spectral component may be incident on a different micro-mirror of the array. Therefore, each micro-mirror may be selectively rotated to direct a particular spectral component of the radiation either toward or away from a source aperture (to irradiate the tissue surface) or a detector (to be detected as transmitted or reflected radiation).
- spectral bands in which radiation is emitted by different radiation sources may partially or completely overlap.
- spectral separation may be effected by another of the components (e.g., source, detector, or optics).
- the absorption of radiation in a particular spectral band may be determined the contributions of various substances or chromophores that absorb electromagnetic radiation of different wavelengths.
- Chromophores are functional groups of molecules that absorb light or electromagnetic radiation to various extents in a spectral band. Each chromophore is characterized by a particular characteristic absorption as a function of wavelength, and which may be used to identify the presence of that molecule.
- chromophores In practice, only a few chromophores contribute to the absorption in the NIR-SWIR range from about 800 nm to about 2400 nm. In this region, major contributions to absorption in the body arise from the presence of (oxy- or deoxy-) hemoglobin, water, and fat and melanin. Other chromophores that may potentially contribute slightly (e.g., about 1 % -3%) to the absorption include myoglobin, cytochrome, bilirubin, lipids and other substances.
- one of the spectral bands may include the SWIR band from about 1400 nm to about 1500 nm, which is strongly absorbed by water.
- Another of the spectral bands may include the SWIR band from about 1000 nm to about 1350 nm, or the SWIR band from about 1500 nm to about 2100 nm. (Radiation in the spectral region from about 1350 nm to 1400 nm, where the absorption by water rapidly changes with wavelength (with a large slope in a curve of absorption versus wavelength), may not be used in some cases
- a rate of change of absorption of radiation as a function of the wavelength may be measured in the spectral region from about 1300 nm to about 1430 nm.
- the absorption by water rapidly changes with wavelength.
- the high rate of change of absorption with wavelength may be exploited to detect the presence of water (or an amount or concentration of water) in the tissue.
- a slope of a graph of absorption (or reflection or transmission) versus wavelength may be calculated.
- the slopes of normal tissue curve 72 and of disease tissue curve 74 noticeably differ from one another in the spectral range of 1300 nm to 1430 nm.
- the measurement of the reflection or transmission may be performed in at least two different but adjacent spectral bands of the SWIR region of the electromagnetic spectrum.
- the results of the reflection or transmission measurement may be analyzed by comparison with previously measured or calibrated results. The comparison may be utilized to determine the state of the subcutaneous tissue.
- one of the spectral bands may be selected such that the reflection or transmission in that band is relatively unaffected by the presence or absence of the medical condition.
- the measured reflection or transmission in this spectral band may serve as a reference.
- the reference measurement may set a baseline value or temporary calibration for measurements in the presence of conditions that are specific to the measurement.
- the conditions may be related to the patient's body (e.g., dimensions or other properties of a skin or tissue surface or body part on which the measurements are made).
- the conditions may be related to drift or transient variation in properties of the measurement unit that is used to perform the reflection or transmission measurements.
- Measurements may be further calibrated by monitoring a dark signal (e.g., when a radiation detector is shielded from radiation) and an intensity of the radiation source (e.g., by providing a direct channel of radiation from the radiation source to the corresponding radiation detector).
- a dark signal e.g., when a radiation detector is shielded from radiation
- an intensity of the radiation source e.g., by providing a direct channel of radiation from the radiation source to the corresponding radiation detector.
- Another of the spectral bands may be selected such that a reflection or transmission measurement in that band is sensitive to the state of the tissue.
- the measurement in that other spectral brand may be indicative of the state of the tissue.
- the state of the tissue may be detected noninvasively.
- one of the spectral bands may include wavelengths of SWIR electromagnetic radiation that are strongly (e.g., almost completely) absorbed by water.
- Another of the spectral bands may include SWIR electromagnetic radiation that is largely transmitted by water.
- one of the spectral bands may include SWIR electromagnetic radiation whose absorption varies rapidly with wavelength (e.g., instead of, or in addition to, the spectral band in which radiation is strongly absorbed).
- Fig. 1A is a schematic drawing of a system for noninvasive analysis of subcutaneous liquids based on reflection of infrared radiation, in accordance with an embodiment of the present invention.
- Liquid analysis system 10 includes reflection measurement unit 12.
- Reflection measurement unit 12 includes infrared radiation source 14 and radiation detector 16.
- Unit aperture 19 on optical head 13 of reflection measurement unit 12 is configured to be placed on or near a tissue surface 22 of a patient so as to measure infrared radiation that is reflected from tissue that is covered by tissue surface 22.
- Liquid analysis system 10 is configured to determine the state of subcutaneous tissue, such as the presence of absence of a subcutaneous medical condition in tissue that is covered by tissue surface 22, or to measure the presence or absence of an administered substance in blood that flows via the tissue.
- Reflection measurement unit 12 may be configured to be held and manipulated by a single hand of a user.
- the user may include a healthcare professional, a caregiver, or the patient.
- Reflection measurement unit 12 may include an internal power source in the form of a battery or other self-contained power source, or may be connectable to an external power source.
- Reflection measurement unit 12, optical head 13, or both may have a generally or substantially cylindrical form, or may have another geometrical form or shape.
- Unit aperture 19 may thus have a substantially round or elliptic shape, or another shape.
- Unit aperture 19 of optical head 13 may include one or more component apertures.
- Fig. IB is a schematic illustration of a plurality of component apertures of an optical head of the system shown in Fig. 1 A.
- Unit aperture 19 includes a plurality of component apertures 40.
- Each component apertures 40 may be configured to enable passage of radiation from a single component infrared source of infrared radiation source 14 or to a component detector of radiation (e.g., infrared) detector 16.
- unit aperture 19 is round and component apertures 40 are arranged in a hexagonal pattern. Other configurations may include other shapes of unit aperture 19 or other arrangements of component apertures 40.
- Infrared radiation source 14 is configured to irradiate tissue surface 22 with SWIR radiation via unit aperture 19 of optical head 13.
- Infrared radiation source 14 may include one or more separate component infrared sources.
- two or more component infrared sources may each produce SWIR radiation in one or more spectral bands.
- infrared radiation source 14 may include tungsten-halogen or other incandescent lamp, a xenon lamp or other gas emission radiation source, a fluorescent radiation source, an electronic radiation source (e.g., light emitting diode, laser diode, or laser), or other radiation source.
- Infrared radiation source 14 may include a single wideband infrared source that emits radiation over two or more spectral bands.
- infrared radiation from a single wideband infrared source may be separately channeled via separate spectral band selection devices (e.g., that include filters, prisms, or gratings) to form effective single-band sources.
- the separate channeling may be performed sequentially to radiate infrared radiation in different spectral bands in quick succession (e.g., less than a millisecond) via a single component aperture 40 of unit aperture 19.
- the radiation from the wideband source may be divided (e.g., using a beam splitter) and concurrently channeled via different band-selection devices to concurrently radiate in different spectral bands via separate component apertures 40 of unit aperture 19.
- Optics 18 of optical head 13 may direct infrared radiation from infrared radiation source 14 out unit aperture 19 (or from a component infrared source of infrared radiation source 14 out a component aperture 40 of unit aperture 19) to tissue surface 22.
- optics 18 may include one or more mirrors, reflectors, light pipes or optical fibers, lenses, filters, gratings, polarizers, beam splitters, prisms, apertures, collimators, shutters, or other components.
- optics 18 may direct radiation from tissue surface 22 (e.g., reflected radiation) via unit aperture 19 to infrared radiation detector 16 (or via a component aperture 40 of unit aperture 19 to a component detector of infrared radiation detector 16).
- optics 18 may function both to direct radiation from infrared radiation source 14 to tissue surface 22, and to direct radiation from tissue surface 22 to infrared radiation detector 16. Alternatively or in addition, separate components of optics 18 may be provided for either directing radiation from infrared radiation source 14 to tissue surface 22 or for directing radiation from tissue surface 22 to infrared detector 16.
- Optics 18 may be or may include a dispersive element (e.g., grating, prism, element with spectrally selective optical layers or coating, or another dispersive element), and a micro-mirror array for directing radiation of one or more selected wavelengths toward unit aperture 19 (e.g., for limiting irradiation of tissue surface 22 to selected wavelengths), or toward infrared detector 16 (e.g., for limiting detection of reflected or transmitted radiation to selected wavelengths).
- a dispersive element e.g., grating, prism, element with spectrally selective optical layers or coating, or another dispersive element
- micro-mirror array for directing radiation of one or more selected wavelengths toward unit aperture 19 (e.g., for limiting irradiation of tissue surface 22 to selected wavelengths), or toward infrared detector 16 (e.g., for limiting detection of reflected or transmitted radiation to selected wavelengths).
- Optics 18 may be configured to direct a portion of radiation that is emitted by infrared radiation source 14 to infrared detector 16. Thus, an intensity of the radiation that is emitted by infrared radiation source 14 may be monitored. Optics 18 may include a shutter or other component that is configured to block radiation (e.g., that is emitted by infrared radiation source 14) from reaching infrared detector 16. When the radiation is blocked, a baseline measurement may be made (e.g., a dark current or a detection level that is due to stray radiation).
- Infrared detector 16 may be configured to detect SWIR radiation from tissue surface 22 that enters reflection measurement unit 12 via unit aperture 19.
- Infrared detector 16 may include one or more component detectors. For example, radiation that is reflected by tissue surface 22 may be enabled to impinge on a component detector of infrared detector 16 via one of component apertures 40.
- Two or more different component radiation detectors may be configured to detect, or be optimized to detect, SWIR radiation in one or more spectral bands.
- a component detector may include a solid state or other photoelectric transducer or photodetector that is configured or optimized for one or more spectral bands of SWIR radiation.
- a component detector may include a thermal detector, a photon detector (e.g., including InGaAS), or another type of wideband detector.
- the temperature of a component detect of infrared detector 16 may be regulated (e.g., via thermoelectric cooling or heating) or may be unregulated.
- Infrared detector 16 or controller 28 may include an amplifier to amplify a detection signal that is produced by infrared detector 16.
- the amplifier may include a trans-impedance amplifier or other amplifier.
- Infrared detector 16 or controller 28 may include a logarithmic converter that enables direct calculation of an absorbance value of the tissue, or of a quantity that is proportional to an absorbance.
- the absorbance data may be used to analyze a liquid, such as water or blood, below tissue surface 22 (e.g., detect a pressure ulcer or a concentration of a drug or other substance in the blood).
- Component apertures 40 may be arranged such that radiation in a particular wavelength band that is emitted by a particular component infrared source of infrared radiation source 14 and that is reflected by tissue surface 22 is likely to impinge on a corresponding (e.g., configured or optimized to detect radiation in that same wavelength band) component detector of infrared detector 16.
- a corresponding e.g., configured or optimized to detect radiation in that same wavelength band
- the positions of a pair of corresponding component apertures 40 may be arranged such that radiation that irradiates tissue surface 22 via one of the corresponding component apertures 40 may be specularly reflected by tissue surface 22 into the other of the pair of corresponding component apertures 40.
- Unit aperture 19 of optical head 13 may be configured to be placed against or near tissue surface 22.
- Optical head 13 may be provided with a removable protective cover 20 that may be placed over unit aperture 19 when reflection measurement unit 12 is in use.
- At least an outer surface of removable protective cover 20 may be constructed of materials that are suitable (e.g., approved by an appropriate organization) for contact with human skin or other tissue surfaces.
- At least a region of protective cover 20 e.g., a region that is configured for placement over unit aperture 19
- Suitable materials may include, for example, rigid vinyl, polycarbonate, POLY IR® plastic materials, or other materials such as poly urethane (PU)b, thermoplastic elastomers (TPE), silicones (LSR) and the like.
- Removable protective cover 20 may include a structure (e.g., tab, projection, notch, clip, or other structure) that cooperates with corresponding structure on optical head 13 to prevent or inhibit removable protective cover 20 from accidentally or unintentionally falling off of optical head 13, e.g., during use.
- Protective cover 20 may be disposable, cleanable, or sterilizable. Removable protective cover 20 may be removed from optical head 13 and replaced (e.g., with a different removable protective cover 20, or with the same removable protective cover 20 after cleaning and sterilization) between uses of reflection measurement unit 12 on different patients. Use of removable protective cover 20 may enable sanitary use of reflection measurement unit 12 on different patients while not exposing reflection measurement unit 12 from repeated cleaning or sterilization.
- Liquid analysis system 10 may include a controller 28.
- Controller 28 may include a microcontroller unit (MCU), or one or more other types of controller, microprocessor or processor. Controller 28 may include for example two or more intercommunicating devices or units. Controller 28 may be configured to control operation of infrared radiation source 14, and to receive signals that are indicative of detected radiation from infrared detector 16.
- controller 28 may include circuitry that is configured to control operation of infrared radiation source 14 and infrared detector 16.
- Controller 28 may be configured to operate in response to operation of user controls 27.
- user controls 27 may include one or more user touch-operable controls, such as pushbuttons, dials, switches, levers, touch-sensitive surfaces, or other touch-operable controls.
- User controls 27 may include other types of controls, such as light-sensitive controls, sound-operated controls, electromagnetically-operable controls, proximity sensors, pressure sensors, or other types of controls.
- Controller 28 may be configured to dynamically adjust the intensity of radiation that is emitted by infrared radiation source 14, e.g., in accordance with intensities that are detected by infrared detector 16. For example, the intensity may be adjusted to accommodate various tissue thicknesses, skin coloration, or other characteristics. The intensities of a component infrared source may be adjusted in accordance with output of another component infrared source.
- Controller 28 may be configured to digitally filter the signals of infrared detector 16, e.g., to remove effects of baseline wandering and artifacts caused by patient movement.
- Controller 28 may include a processor or processing units that may be configured to operate in accordance with programmed instructions. Controller 28 or a processor of controller 28 may communicate with an external device 30 via connection 36.
- External processing device 30 may represent a device with processing capability, such as a computer, smartphone, or other device. External processing device 30 may be portable (e.g., a portable computer or smartphone) or may be fixed (e.g., a server). External processing device 30 may include or communicate with an input device 34 (e.g., keyboard, keypad, touch screen, pointing device, or other input device), an output device 32 (e.g., display screen or other output device), or both.
- Connection 36 may represent a wire or cable connection, a wireless connection (e.g., Bluetooth), a network connection, or another communications connection.
- External processing device 30 may be utilized to communicate commands or programmed instructions to control operation of controller 28.
- external processing device 30 may be operated using input device 34 to download parameters or instructions (e.g., a measurement protocol) to controller 28.
- Measured results from operation of reflection measurement unit 12, or results of analysis of the measured results, preformed by, for example, external processing device's processor 38, may be output by output device 32 of external processing device 30 for examination or review by a user of liquid analysis system 10.
- External processing device 30 may communicate (e.g., via a network such as the Internet) with one or more other processors, computers, or servers. For example, measure spectral reflection or transmission data may be communicated to a remote server. The remote server may analyzed the transmitted data and return a diagnosis or other indication of a state of a medical condition.
- Controller 28 may communicate with memory 24 (and/or external processing device's memory 39).
- Memory 24 may include one or more volatile or nonvolatile memory devices. Memory 24 may be incorporated within reflection measurement unit 12, external processing device 30, or elsewhere. Memory 24 may be utilized to store, for example, programmed instructions for operation of controller 28, data or parameters for use by controller 28 during operation, or results of operation of controller 28.
- Controller 28 and or processor 38 may communicate with data storage device 26.
- Data storage device 26 may include one or more fixed or removable nonvolatile data storage devices. Data storage device 26 may be incorporated within reflection measurement unit 12, external processing device 30, or elsewhere.
- data storage device 26 may include a computer readable medium for storing program instructions for operation of processing unit of controller 28 or of external processing device 30. It is noted that data storage device 26 may be remote from the processing unit. In such cases data storage device 26 may be a storage device of a remote server storing an installation package or packages that can be downloaded and installed for execution by the processing unit.
- Data storage device 26 may be utilized to store data or parameters for use by controller 28 during operation or results of operation of controller 28 (e.g., detection of radiation).
- Data storage device 26 may be used to store data that relates spectral absorption, transmission, or reflection characteristics of tissue surface 22 to one or more medical conditions.
- the data may be stored in the form of a database.
- Processor or controller 28, or another processor or controller may be configured to carry out methods as described herein.
- a system for noninvasive analysis of subcutaneous liquids may be based on measured transmission of SWIR radiation.
- FIG. 2 A is a schematic drawing of a measurement unit of a system for noninvasive analysis of subcutaneous liquids based on transmission of infrared radiation, in accordance with an embodiment of the present invention.
- Transmission measurement unit 50 may be used in a system for noninvasive analysis of subcutaneous liquids, such as in liquid analysis system 10 (e.g., in place of, or in addition to, reflection measurement unit 12 of Fig. 1A). Transmission measurement unit 50 is configured to measure transmission through a body part 52.
- body part 52 may represent a part of the body (e.g., ear, finger, fold of skin) through which a measurable fraction of SWIR radiation is transmitted.
- Transmission measurement unit 50 includes radiation source arm 54 and detection arm 55.
- Radiation source arm 54 may include infrared radiation source 14 and source optics 53a.
- infrared radiation source 14 may be located outside of radiation source arm 54.
- source optics 53a may be configured (e.g., with a mirror, light pipe, or optical fiber) to convey radiation from infrared radiation source 14 to source arm aperture 57a.
- infrared radiation source 14 may include two or more separate component infrared sources.
- Source optics 53a may be configured to convey radiation from the component infrared sources, concurrently or sequentially, to source arm aperture 57 a, or to separate component apertures of source arm aperture 57a.
- Source optics 53a may be or may include a dispersive element (e.g., grating, prism, element with spectrally selective optical layers or coating, or another dispersive element), focusing optics, and a micro-mirror array for directing radiation of one or more selected wavelengths of radiation from infrared radiation source 14 toward source arm aperture 57 a.
- a dispersive element e.g., grating, prism, element with spectrally selective optical layers or coating, or another dispersive element
- focusing optics e.g., focusing optics, and a micro-mirror array for directing radiation of one or more selected wavelengths of radiation from infrared radiation source 14 toward source arm aperture 57 a.
- Detection arm 55 may include infrared detector 16 and detector optics 53b.
- infrared detector 16 may be located outside of detection arm 55.
- detector optics 53b may be configured (e.g., with a mirror, light pipe, or optical fiber) to convey radiation from detection arm aperture 57b to infrared detector 16.
- infrared detector 16 may include two or more separate component detectors.
- Detector optics 53b may be configured to convey radiation from detection arm aperture 57b, concurrently or sequentially, to component detectors of infrared detector 16, or from separate component apertures of detection arm aperture 57b to component detectors of infrared radiation detector 16.
- Detector optics 53b may include a dispersive element (e.g., grating, prism, element with spectrally selective optical layers or coating, or another dispersive element), focusing optics, and a micro-mirror array for directing radiation of one or more selected wavelengths of radiation from detector arm aperture 57b toward infrared detector 16.
- a dispersive element e.g., grating, prism, element with spectrally selective optical layers or coating, or another dispersive element
- focusing optics e.g., focusing optics
- micro-mirror array for directing radiation of one or more selected wavelengths of radiation from detector arm aperture 57b toward infrared detector 16.
- Radiation source arm 54, detection arm 55, or both may be rotated outward (away from one another) or inward (toward one another). Outward rotation of radiation source arm 54 or detection arm 55 may enable insertion of body part 52 between the arms. Inward rotation of radiation source arm 54 or detection arm 55 may bring source arm aperture 57a and detection arm aperture 57b into contact with or near to body part 52. Source arm aperture 57a and detection arm aperture 57b may each be covered with a removable protective cover 20.
- a rotation mechanism 56 may be configured to enable the outward or inward rotation of radiation source arm 54 and detection arm 55.
- rotation mechanism 56 may include a hinge, gimbal, bearing, or other mechanism to enable rotation of radiation source arm 54 or detection arm 55.
- a single rotation mechanism 56 may be provided (e.g., a single hinge mechanism) between radiation source arm 54 and detection arm 55 (e.g., as shown schematically in Figs. 2B and 2C).
- Rotation mechanism 56 may include a spring, latch, or other mechanism to hold radiation source arm 54 and detection arm 55 against body part 52 when body part 52 is inserted between radiation source arm 54 and detection arm 55.
- rotation mechanism 56 may attach transmission measurement unit 50 to body part 52.
- Rotation mechanism 56 may be configured to enable measurement of a thickness of body part 52.
- rotation mechanism may include an encoder or other measuring device for measuring an angle of rotation of rotation mechanism 56.
- rotation mechanism may include an angular scale or mechanical rotation gauge for determining an angle of rotation of rotation mechanism 56.
- a measured rotation angle, together with a known distance from (e.g., and axis of rotation of) rotation mechanism 56 from source arm aperture 57a or from detection arm aperture 57b may be used (e.g., by a processor or controller) to calculate the thickness.
- transmission measurement unit 50 may be operated to measure of transmission of SWIR radiation from infrared radiation source 14 through body part 52 to infrared detector 16.
- Fig. 2B schematically illustrates attachment of the measurement unit of Fig. 2A to a finger.
- transmission measurement unit 50 may be clipped to finger tip 60 to measure transmission of SWIR radiation through finger tip 60.
- the transmission measurement may be indicative of a medical condition, such as the concentration of a substance in blood that flows through finger tip 60.
- FIG. 2C schematically illustrates attachment of the measurement unit of Fig. 2A to an ear.
- transmission measurement unit 50 may be clipped to outer ear 62 to measure transmission of SWIR radiation through outer ear 62.
- the transmission measurement may be indicative of a medical condition, such as the concentration of a substance in blood that flows through outer ear 62.
- a reflection or transmission measurement may be utilized to characterize tissue in a patient.
- a spectral reflectance measurement R(X) may be expressed as
- ⁇ ( ⁇ ) is a measured source intensity
- 1( ⁇ ) is a measured reflected intensity
- ⁇ ( ⁇ ) is a baseline measurement (e.g., measured when infrared radiation source 14 is turned off or when infrared detector 16 is covered, e.g., by a shutter).
- Source intensity ⁇ ( ⁇ ) may be monitored continuously (e.g., by a dedicated detector), or may be measured in the absence of tissue (e.g., a skin surface or body part) in the optical path from infrared radiation source 14 to infrared detector 16.
- baseline measurement ⁇ ( ⁇ ) may be ignored when ⁇ ( ⁇ ) is much smaller than ⁇ ( ⁇ ) or 1( ⁇ ).
- the relative spectral absorbance ⁇ ( ⁇ ), which may be used to characterize the tissue, may be calculated by:
- the dimensionless value is the relative spectral absorbance
- L is the path-length or tissue penetration depth
- an is the reflection coefficient.
- the relative absorbance A(X) corresponds to spectral extinction, which results from both absorption and scattering.
- Reflectance measurements in two or more spectral bands, Mi may be performed on a single region of skin or tissue to yield separate measured values of
- the spectral bands may include two or more of the wavelength ranges -1400 nm - 1500 nm (strongly absorbed by water), -1000 nm - 1350 nm (no strong absorption by water), and -1500 nm - 2100 nm (no strong absorption by water).
- the differential absorption AD I // may be calculated from measurements in two wavelength bands
- Aref and R re f refer the absorbance and reflectance in one of the spectral bands that serves as a reference band.
- radiation in the reference band may be largely absorbed, scattered, or transmitted whether or not a medical condition to be detected is present.
- the wavelength range of -1400 nm - 1500 nm (strong water absorption), a portion of this range, or another similarly unaffected spectral range may be selected as the reference band.
- the operating band may be detectibly dependent on the presence of absence of the medical condition.
- the operating band may include one or both of the spectral ranges -1000 nm - 1350 nm, -1550 nm - 2100 nm, one or more portions of one or both spectral ranges, or another suitable spectral range.
- the symbol - indicates an approximation (e.g., ⁇ 10%).
- the differential absorption may be related to the state of the tissue (e.g., presence, absence, degree, or other state of a medical condition).
- a database of previous measurement results may associate a value of a differential absorption with a state of a medical condition such as inflammation (e.g., otitis media, or other inflammation), tumor (e.g., in the colon, or elsewhere), or other conditions.
- the differential absorption value may be used to differentiate between conditions (e.g., inflammation and tumor, healthy and diseased tissue), detect or measure liquid within tissue, or other conditions.
- reflection measurements may be made on a region of a tissue surface when the underlying tissue is expected to be healthy (e.g., based on other medical indications), and another where presence of unhealthy tissue is suspected.
- chromophore content may be measured quantitatively.
- differentiation is limited to two states, e.g., healthy or diseased (e.g., presence of pressure ulcer indicated by accumulation of subcutaneous liquid in the) tissue.
- a state of a medical condition may be determined by calculating the tissue liquid index (TLI), the sub-dermal fluid index (SDFI), or another quantity.
- TLI tissue liquid index
- SDFI sub-dermal fluid index
- a parameter C such as TLI, SDFI, or another parameter, can be defined as a normalized difference of the reflectance as measured at two different wavelength bands
- C may be approximated by
- Fig. 3 shows an example of a graph of spectral reflectance.
- Graph 70 shows measured reflectance in arbitrary units as a function of wavelength.
- Normal tissue curve 72 may represent spectral reflectance for normal, or healthy, tissue.
- Diseased tissue curve 74 may represent spectral reflectance for diseased, or unhealthy, tissue.
- the spectral transmittance of blood 73 ⁇ 4 may be expressed as
- ⁇ ( ⁇ ) represents the absorption coefficient of blood and (e.g., in units of cm "1 ), respectively, at wavelength ⁇
- ( ⁇ ) is the absorption coefficient of additional components of the tissue
- L is the length of the absorbing path (e.g., in cm).
- ⁇ ( ⁇ ) is the detected intensity of transmitted radiation
- ⁇ ( ⁇ ) is the intensity of incident radiation.
- T%s the spectral transmittance of a mixture of blood and an introduced substance
- the absorption coefficients may relate to the concentrations of blood CB and of the introduced substance Cs:
- 8B and 8s represent the absorptivity coefficients of blood and of the introduced substance (e.g., in units of l- moi ⁇ cm 1 or l- g ⁇ crn 1 ; also referred to as the specific absorption coefficient or mass absorption coefficient), respectively.
- the relative absorbance As (dimensionless) at wavelength ⁇ may be related to the concentration of introduced substance:
- the relative absorbance may be expressed as a linear equation:
- the normalized spectral transmittance 5 at a wavelength ⁇ ⁇ may be calculated from a measuremen
- [0013 1 ] is a measured radiation intensity at wavelength ⁇ ⁇ for measurement k, being proportional to is a reference signal for a measurement ko made prior to introduction of the substance into the blood, being proportional to
- the differential spectral absorbance Amg for measurement k at two wavelengths ⁇ and ⁇ .2 may thus be calculated as
- TB and T%s may represent relative spectral transmittances of blood and of a mixture of blood and a introduced substance measured at two wavelengths ⁇ and /1 ⁇ 2:
- [00134] represent the differential absorption coefficients of blood and of the introduced substance, respectively.
- the normalized spectral transmittance 5 at two wavelengths ⁇ and ⁇ 2 may be calculated from measurement k as:
- the differential spectral absorbance measurement may eliminate the effects of background materials. For example, if the absorption and scattering by the background materials (e.g., tissue components other than water, or a substance that is introduced into the blood) are substantially constant in both measured spectral bands, than the differential spectral absorbance may be indicative of the water content of the tissue (e.g., as indicative of the presence or absence of a medical condition in which fluids accumulate in the tissue, or indicative of water content of blood).
- a known relationship between the differential spectral absorbance and a concentration of the substance in the blood may be applied to the measured differential spectral absorbance to determine a concentration of the substance in the blood. For example, the known relationship be applied as a parameterized formula expressing the relationship (e.g., a polynomial or other formula), as a lookup table, or in another manner.
- Fig. 4 shows a graph of an example of a relationship of absorbance to concentration of a substance.
- Line 82 of graph 80 shows a relationship between a relative absorbance
- the relationship may be derived from laboratory measurements 84, e.g., from transmission measurements on cuvettes containing various concentrations of the substance in blood.
- a relationship may be derived by application of a fitting technique to fit line 82 to laboratory measurements 84.
- Fig. 5 is a flowchart depicting a method for noninvasive analysis of subcutaneous liquids, in accordance with an embodiment of the present invention.
- Operations of subcutaneous liquid analysis method 100 may be executed by a processor of a controller of a device for subcutaneous liquid analysis, or by a processor that is in communication with a controller of a device for subcutaneous liquid analysis.
- Execution of subcutaneous liquid analysis method 100 may be initiated by a user of a device for subcutaneous liquid analysis.
- a user may operate a control to initiate execution of subcutaneous liquid analysis method 100.
- execution of subcutaneous liquid analysis method 100 may be initiated automatically when a device for subcutaneous liquid analysis is activated (e.g., turned on), and when it is detected (e.g., by an optical sensor or by a proximity sensor) that one or more apertures of the device are in contact with a tissue surface.
- the tissue may be irradiated with SWIR radiation in a spectral band that is strongly absorbed by water (block 110).
- a tissue surface may be irradiated with SWIR radiation in the wavelength range from about 1400 nm to about 1500 nm.
- the radiation may originate from a wideband source (e.g., an incandescent or other thermal source, or from a fluorescent source), or from a narrowband source (e.g., laser diode or light emitting diode).
- the irradiation may be filtered or otherwise manipulated.
- radiation that is emitted by a wideband radiation source may be filtered or otherwise manipulated to select only that radiation that is within the water-absorbed spectral band.
- the tissue may be irradiated with SWIR radiation in a spectral band that is adjacent to the water-absorbed spectral band (block 120).
- a gap between the adjacent spectral band and the water-absorbed spectral band may be no more than 200 nm. In some cases, the gap may be no more than 100 nm.
- a single wideband source may produce both the radiation in the water-absorbed spectral band and in the adjacent spectral band.
- the radiation in the adjacent spectral band may be isolated from radiation that is emitted by a wideband source prior to irradiation of the tissue.
- the detector is configured to produce a signal that is indicative of an intensity of the emerging radiation.
- one or more detectors may be configured to detect radiation that emerges from the tissue surface that is irradiated.
- optics of the radiation source and the radiation detector may be aimed at a single tissue surface.
- the detector is configured to measure backscattered or reflected radiation.
- the detector may be configured to detect radiation that emerges from a tissue surface on the opposite side of the tissue from the tissue surface that is irradiated. In this case, the detector is configured to measure radiation that is transmitted by the tissue.
- each detector may be constructed of a material that produces an electric signal only when irradiated with radiation in one of the spectral bands.
- detector optics e.g., including a filter or grating
- the detector may be configured to detect radiation in both spectral bands. In this case, separate measurement of the emerging radiation in the different spectral bands may be effected by separate (e.g., sequential or alternating) irradiation of the tissue with radiation in each of the spectral bands.
- emerging radiation may be measured at different distances from a location of the irradiation.
- emerging radiation may be measured concurrently by a plurality of detectors that are arranged at different distances from a location on the tissue surface that is irradiated.
- emerging radiation may be measured sequentially in time at different distances by one or more detectors whose distance from the location of irradiation may be changed (e.g., automatically or manually).
- a detector may be provided with a sensor or mechanism (e.g., encoder or other sensor or mechanism) that is configured to measure a distance between a detector and the radiation source.
- signals received from each detector may correspond to the distance of the detector from the light source.
- the shape and/or intensity of a signal received by a detector may correspond to a medical condition in the tissue, for example shape of a signal changed in measurements for healthy tissue and for deep tissue injury, so that the shape of the signal received for a healthy tissue changes when measuring an injured tissue of the same subject (e.g., person).
- the shape of a signal may change because of different types of chromophores and different types of chemical functional groups on a chromophore. For example a phenol ring on a chromophore will have different absorption graph shape in comparison to a CO chemical bond, CH chemical bond, or CN chemical bond.
- Absorption graph different shape means different location of the absorption peak or peaks in different wavelengths and at different peak heights (amplitudes).
- a plurality of detectors may be used, each of the plurality of detectors may have a different distance from the radiation source. It should be appreciated that the signal received by each detector may have different amplitudes.
- the processor or controller may combine the readings of the plurality of detectors and calculate the slope of the combined absorption graph (e.g., a graph that represents the result of combining all detected amplitudes). A change in the state of the tissue may be determined, according to some embodiments, when a change in the slope of the combined absorption graph is detected (e.g., by processor 38 and/or controller 28 in Fig. 1).
- Detection of the emerging radiation may be preceded by, followed by, or may be concurrent with one or more calibration, baseline, or reference measurements.
- a baseline or dark measurement may be made when the radiation source is not being operated.
- the baseline measurement may determine a signal that is produced by the detector (e.g., due to detector electronics or to stray radiation impinging on the detector surface) when no radiation of interest is present.
- a calibration measurement may be made when radiation that is emitted by the source is directly (e.g., not via tissue) conveyed to the detector.
- Such a calibration measurement when made concurrently with, or immediately prior to or after, the measurement of emerging radiation may enable compensation for drifting in source intensity or detector sensibility.
- a reference measurement may be made on the radiation that emerges from the tissue under known conditions (e.g., on a skin surface that is known to overlie healthy tissue, or prior to introduction of a substance into the blood).
- the measurements of emerging radiation may be used to calculate a relative absorption by the tissue (block 140).
- a relative reflectance may be calculated by calculating a ratio of a measured intensity of reflected (e.g., due to backscattering) radiation in one of the spectral bands to the measured intensity of reflected radiation in another spectral band.
- a relative absorption may be inferred from the relative reflectance, e.g., on the assumption that a characteristic penetration depth of the radiation is the same in both spectral bands. If the characteristic penetration depth of the radiation is known (e.g., from laboratory experiments), a differential absorbance may be calculated.
- a relative transmission may be calculated by calculating a ratio of a measured intensity of transmitted radiation in one of the spectral bands to the measured intensity of transmitted radiation in another spectral band. Since the path length through the tissue is the same for both spectral bands, a relative absorption may be inferred from the relative transmission. If the thickness of the tissue (L) is known (or may be estimated) and constant, a differential absorbance of the tissue may be calculated.
- the relative differential absorbance As (dimensionless) at two wavelengths ⁇ and ⁇ .2 is related to the concentration of introduced substance as:
- Raman spectroscopy as described in further detail below, may be employed to analyze the measurement data, and determine changes in concentration of any chemical compound inside the tissue due to, for example, a deep tissue injury.
- the calculated relative absorption may be utilized to determine a state of the tissue (block 150).
- a calculated differential absorbance, relative reflection, relative transmission, or other calculated value that is related to relative absorption may be compared to previously measured values.
- the previously measured values may relate to a particular body part, suspected medical condition, introduced substance, or may otherwise relate to a specific state that is being examined.
- the comparison may include substitution of the calculated value in a functional relationship, may be used to retrieve an indication of the state of the tissue from a lookup table, or may be otherwise utilized in determining a state of the tissue.
- deep tissue injuries may include presence of liquids at depths larger than about 5mm compared to a corresponding region of a healthy tissue (e.g., of a healthy patient).
- deep tissue injuries may include increasing concentration (over time) of substances that are products of ischemic processes (causing damage to the tissue) such as free fatty acids and/or glycerol which are the breakdown products of the fatty part of the tissue (triglyceride).
- triglyceride may appear in the form of very low density lipoproteins (VLDL) while in other tissue the structure of triglyceride is maintained.
- VLDL very low density lipoproteins
- Accumulation of other substances may also indicate presence of a deep tissue injury. Therefore, in order to determine a state of deep tissue injury, calibration may be initially performed to identify substances in tissue indicating such an injury. Using the calculated relative absorption a state of deep tissue injury may be therefore determined, as described above.
- a reflectance measurement may include detecting reflected radiation at different lateral distances from a radiation source. In some embodiments, analysis of such reflectance measurements at different distances may indicate a depth within the tissue of a detected feature.
- FIG. 6A schematically illustrates a system for measurement of reflection at a distance from a radiation source, in accordance with an embodiment of the present invention.
- reflection measurement system 200 may include a source unit 202 and one or more detection units 204.
- Source unit 202 may include at least one infrared (IR) radiation source 14 and source optics 18a (e.g., lenses etc.) for directing a beam of radiation, e.g., into a tissue surface 22.
- Each detector unit 204 may include at least one IR detector 16 and detector optics 18b (e.g., lenses etc.) for directing radiation, for instance radiation emerging from tissue surface 22, toward infrared detector 16.
- Detector unit 204 may be located at a measurement distance 206 from source unit 202.
- measurement distance 206 may correspond to a distance between a center of an aperture of source unit 202 to a center of detector unit 204, and/or another measurement that characterizes a lateral distance between source unit 202 and detector unit 204.
- At least one of detector unit 204 and source unit 202 may be moveable relative to one another so as to change measurement distance 206.
- reflectance measurements at different measurement distances 206 may be measured sequentially in time.
- the distance 206 between detector unit 204 and source unit 202 at the time of a measurement may be determined with a dedicated mechanism and/or sensor.
- detector unit 204 and source unit 202 may be mounted on a fixture that includes a mechanism for adjusting a distance therebetween.
- the fixture may include a telescoping rod, a bendable joint, or any other mechanism to adjust a distance between detector unit 204 and source unit 202 in a controllable manner.
- the fixture may include fixed stops at known distances between detector unit 204 and source unit 202.
- a sensor may be provided to measure a distance between detector unit 204 and source unit 202.
- a telescoping rod or bendable joint may be provided with an encoder to measure relative movement between detector unit 204 and source unit 202.
- a rangefinder sensor may directly measure a distance between detector unit 204 and source unit 202.
- At least one source unit 202 and at least one detector unit 204 may be combined in a single measurement unit to concurrently measure radiation that emerges from tissue surface 22 at different lateral distances from source unit 202.
- Fig. 6B schematically illustrates an arrangement of a measurement head for concurrent measurement of radiation that emerges from a surface at different lateral distances from the radiation source, in accordance with an embodiment of the present invention.
- each measurement head 208 may include a single source unit 202 surrounded by a plurality of detector units 204 and separated by two different lateral distances form source unit 202.
- source unit 202 is surrounded by an arrangement of inner detector units 204a, each laterally separated from source unit 202 by a distance that is substantially equal to first distance 206a.
- Inner detector units 204a are surrounded by an arrangement of outer detector units 204b, each separated from source unit 202 by a lateral distance that is substantially equal to second distance 206b.
- second distance 206b may be larger than first distance 206a.
- an arrangement shown in Fig. 6B has been selected for illustrative purposes only. An actual arrangement may differ from the arrangement shown in Fig. 6B.
- an arrangement may include detector units 204 at more than two distances from a source unit 202.
- An arrangement may include a different pattern of detector units and/or of source units.
- An arrangement may include more than one source unit 202.
- different source units 202 may produce radiation with different wavelengths.
- a center unit may include a detector unit 204 (e.g., surrounded by sources 202).
- measurement of a distance to a detected feature may be advantageous.
- measurement of a distance may enable differentiation between a superficial pressure ulcer and a deep ulcer.
- such measurement of a distance may enable differentiation between a deep pressure injuries and superficial pressure ulcers.
- a distance between the light source and the light sensor may be predetermined.
- determination of such distance may allow determination of a medical condition in the tissue (e.g., deep tissue injury) due to changes in signal from a detector having a determined distance to the light source.
- Pressure ulcers are areas of soft tissue breakdown that result from sustained mechanical loading of skin and underlying tissues. They can interfere with quality of life, activities of daily living, and rehabilitation and, in some cases, may be life threatening. Pressure ulcers can develop either superficially or deep within the tissues, depending on the nature of the surface loading and the tissue integrity. The superficial pressure ulcer type forms within the skin, with maceration and detachment of superficial skin layers. When allowed to progress, the damage may result in an easily detectable superficial ulcer.
- Deep tissue ulcers arise in muscle layers covering bony prominences and are mainly caused by sustained compression of tissue. Deep tissue ulcers may develop at a faster rate than superficial ulcers, and result in more extensive ulceration with an uncertain prognosis.
- NIR and SWIR radiation may be strongly scattered by such tissue.
- the free scattering length may be in the range of about 0.3 mm to about 1 mm. In some embodiments, the scattering may be strongly forward peaked. Beyond a free transport scattering length (e.g., about 1 mm), directional correlation with the direction of the incident irradiation (the correlation between the actual direction and the direction of incidence) is lost such that radiation transport may be modeled as photon diffusion. In a photon diffusion model, scattering may be isotropic at locations that are more distant from radiation sources and boundaries than several times the free scattering length. Photons may follow complex trajectories that are considerably longer than the geometrical distance between the radiation source and the radiation detector.
- FIG. 7 schematically illustrates paths of incident radiation to different detector locations, in accordance with an embodiment of the present invention.
- a deep lesion 210 may be distant from tissue surface 22.
- Incident radiation 214 may enter tissue surface 22 (e.g., from a source unit 202 as shown in Fig. 6A).
- Emerging radiation 216a, 216b, and 216c may emerge from tissue surface 22 at different distances from incident radiation 214, having traversed radiation paths 218a, 218b, and 218c respectively within the tissue. It should be noted that as shown in Fig. 7, only radiation path 218c passes through deep lesion 210. Thus, only emerging radiation 216c may correspond to and be attenuated by water absorption in deep lesion 210.
- a connection between measured absorption and differences in concentration of subcutaneous liquids may be described with reference to a modified Beer-Lambert law:
- ⁇ ( ⁇ ) is a measured source intensity
- ⁇ ( ⁇ ) is a measured reflected intensity
- ⁇ ( ⁇ ) is the measured absorption (attenuation)
- 3 ⁇ 4 and d are the absorptivity coefficients and concentrations of different absorbing compounds.
- the path length ⁇ L> ⁇ (F d) represents the total mean optical path in the tissue (e.g., in units of centimeters), where d is the distance between the point of incident radiation 214 and one of emerging radiation 216a, 216b, or 216c, and F is a scaling factor (related to the optical path length).
- the scattering coefficient may be expressed as where g is the
- the ratio for a penetration depth below tissue surface 22 may be twice the lateral distance d between the points of incident radiation 214 and the emerging radiation 216a, 216b, or 216c.
- Differences in concentration of subcutaneous liquids may be estimated from the slope of the attenuation with respect to distance d, where
- Ai and A2 representing differential absorptions Aoig as described above that are measured with two different lateral distances d between incident radiation 214 and emerging radiation 216a, 216b, or 216c.
- the measurements may be analyzed to yield a change in concentration of water.
- Raman spectroscopy may be employed to analyze the measurement data.
- a complementary scattering mechanism to excite the molecules into the vibrational states may be achieved via the visible excitation wavelengths.
- Raman scattering may be an inelastic scattering which is usually generated by intensive monochromatic light (e.g., laser) in the visible, near infrared, or near ultraviolet (UV) region.
- intensive monochromatic light e.g., laser
- UV near ultraviolet
- the energy of laser photons may be changed after the excitation laser interacts with the vibrating molecules or the excited electrons in the sample. As a spontaneous effect, photons may transfer the excitation energy to change the molecule from the ground state to a virtual state.
- the excited molecule may then return to a different rotational or vibrational state after emitting a photon.
- ⁇ incident wavelength
- the scattered light is known as a Raman shift. It is related to characteristic oscillation frequencies of the molecule, and may correspond to the oscillations of a single molecular bond or the larger fragment of a molecular network.
- intensity of the Raman signal may be inversely proportional to ⁇ 4 so application of a VIS or UV laser as the excitation source may be more effective than an IR one if the intensity of Raman scattering was considered.
- practical efficiency of Raman scattering versus excitation wavelength may also depend on dimensions of the investigated structures.
- fluorescence induced by the laser beam may be also taken into account.
- Fluorescence is the strongest for the excitation wavelength ⁇ range extending from 270 to 700 nm but its influence can be different for various materials. It is particularly strong for organic materials, so the excitation range in VIS and near UV is not appropriate for their sampling.
- NIR lasers e.g., in the range of 785-1064 nm
- detector types e.g., InGaAs, MCT, etc.
- Raman range of systems using such detectors may begin at about 800 crrT 1 for excitation wavelength equal to 830 nm.
- a measurement system (such as reflection measurement system 200 shown in Fig. 6A) to employ Raman spectroscopy may include at least one light source (e.g., such as source unit 202 shown in Fig. 6A).
- the source unit may include a diode laser (e.g., -lOOmW), light emitting diodes (LEDs) and/or a combination thereof.
- Raman measurement system may include at least one light sensor (e.g., such as detection unit 204 shown in Fig. 6A).
- the light sensor may include a thermoelectric cooled charge coupled detector (CCD) and/or a spectrograph.
- CCD thermoelectric cooled charge coupled detector
- the Raman measurement system may include optical elements (e.g., such as optics 18a, 18b shown in Fig. 6 A) with at least one of beam expanding/focusing lenses, laser-line filter, dichroic mirrors, holographic rejection (notch) filters, low-pas filter, and fibers.
- optical elements e.g., such as optics 18a, 18b shown in Fig. 6 A
- the 830nm excitation wavelength may be used in order to reduce the influence of background fluorescence signal.
- Raman measurement system may indicate a change in concentration of a chemical compound within the tissue, for example due to deep tissue injury after calibration with healthy tissue is carried out.
- a Raman measurement system may include at least one processor (such as controller 28 shown in Fig. 1A) and/or communicate with at least one processor (such as external processing device 30 shown in Fig. 1A) so as to allow analysis of the measured data according to Raman spectroscopy.
- analysis may include measurements of the distance between the light source and the light sensor.
- analysis may allow determination of liquid accumulation and/or determination of concentration of chemical compounds within the tissue (e.g., myoglobin, triglycerides, proteins, etc) and thereby determine deep tissue injuries if a change in the concentration corresponds to deep tissue injuries.
- such analysis may allow determination of at least one substance secreted as a result of a deep tissue injury.
- the Raman intensity may be 10 "6 to 10 "9 times less than that of Rayleigh scattering.
- a controlled cyclic change in external conditions applied on a region of the skin may also allow determination of deep tissue injuries.
- applying pressure e.g., measuring with a pressure sensor
- applying heat e.g., measuring with a temperature sensor
- pressure may be applied in a periodical (e.g., sinusoidal) regime to determine presence of a deep tissue injury.
- an at least partially transparent (to visible and/or IR radiation) biodegradable element for instance an elastomer or other soft plastic, may be placed upon the at least one radiation detector as a cover so as to allow protection of sensors (e.g., from gels applied on the skin).
- biodegradable element may be transparent at least 90%.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Public Health (AREA)
- Pathology (AREA)
- Dermatology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Optics & Photonics (AREA)
- Dentistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/627,470 US10709365B2 (en) | 2014-08-21 | 2017-06-20 | System and method for noninvasive analysis of subcutaneous tissue |
PCT/IL2018/050748 WO2018235091A2 (en) | 2017-06-20 | 2018-07-10 | System and method for noninvasive analysis of subcutaneous tissue |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3641634A2 true EP3641634A2 (en) | 2020-04-29 |
EP3641634A4 EP3641634A4 (en) | 2021-03-10 |
Family
ID=64735573
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP18820207.1A Pending EP3641634A4 (en) | 2017-06-20 | 2018-07-10 | System and method for noninvasive analysis of subcutaneous tissue |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP3641634A4 (en) |
CN (1) | CN110996773A (en) |
CA (1) | CA3067312C (en) |
IL (2) | IL285975B2 (en) |
WO (1) | WO2018235091A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB202103265D0 (en) * | 2021-03-09 | 2021-04-21 | Univ Oxford Innovation Ltd | Vascular imaging tool |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69903306T2 (en) * | 1998-07-07 | 2003-05-22 | Lightouch Medical, Inc. | METHOD FOR TISSUE MODULATION FOR QUANTITATIVE NON-INVASIVE IN VIVO SPECTROSCOPIC ANALYSIS OF TISSUE |
US20030139667A1 (en) * | 2000-04-13 | 2003-07-24 | Hewko Mark D. | Tissue viability/health monitor utilizing near infrared spectroscopy |
WO2005050156A2 (en) * | 2003-11-18 | 2005-06-02 | Chameleon Medical Innovation Ltd. | Measurement system and method for use in determining the patient's condition |
AU2009204140B9 (en) * | 2008-01-08 | 2014-03-13 | Smith & Nephew Plc | Sustained variable negative pressure wound treatment and method of controlling same |
WO2013160780A1 (en) * | 2012-04-23 | 2013-10-31 | I.R.Med Ltd. | Short-wave infrared imaging and spectroscopy technique for inflammation classification and tumor and inflammation differentiation in human tissues inside the body |
RU2616653C2 (en) * | 2012-06-05 | 2017-04-18 | Хайпермед Имэджинг, Инк. | Methods and device for coaxial image forming with multiple wavelengths |
US10772541B2 (en) * | 2014-08-21 | 2020-09-15 | I. R. Med Ltd. | System and method for noninvasive analysis of subcutaneous tissue |
US10709365B2 (en) * | 2014-08-21 | 2020-07-14 | I. R. Med Ltd. | System and method for noninvasive analysis of subcutaneous tissue |
US20160051147A1 (en) * | 2014-08-21 | 2016-02-25 | Irmed | System and method for noninvasive analysis of subcutaneous tissue |
WO2016069788A1 (en) * | 2014-10-29 | 2016-05-06 | Spectral Md, Inc. | Reflective mode multi-spectral time-resolved optical imaging methods and apparatuses for tissue classification |
-
2018
- 2018-07-10 CA CA3067312A patent/CA3067312C/en active Active
- 2018-07-10 WO PCT/IL2018/050748 patent/WO2018235091A2/en unknown
- 2018-07-10 EP EP18820207.1A patent/EP3641634A4/en active Pending
- 2018-07-10 IL IL285975A patent/IL285975B2/en unknown
- 2018-07-10 CN CN201880051975.3A patent/CN110996773A/en active Pending
-
2019
- 2019-12-12 IL IL271377A patent/IL271377B/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP3641634A4 (en) | 2021-03-10 |
WO2018235091A3 (en) | 2019-02-21 |
IL271377B (en) | 2021-08-31 |
IL285975A (en) | 2021-10-31 |
CA3067312C (en) | 2022-05-10 |
IL285975B1 (en) | 2023-08-01 |
IL271377A (en) | 2020-01-30 |
CN110996773A (en) | 2020-04-10 |
IL285975B2 (en) | 2023-12-01 |
WO2018235091A2 (en) | 2018-12-27 |
CA3067312A1 (en) | 2018-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10772541B2 (en) | System and method for noninvasive analysis of subcutaneous tissue | |
US20200337604A1 (en) | System and method for noninvasive analysis of subcutaneous tissue | |
CA2958667A1 (en) | System and method for noninvasive analysis of tissue | |
KR102303829B1 (en) | Noninvasive apparatus for testing glycated hemoglobin and noninvasive method for testing glycated hemoglobin | |
US7330746B2 (en) | Non-invasive biochemical analysis | |
EP0160768B1 (en) | Spectrophotometric apparatus for the non-invasive determination of glucose in body tissues | |
US8750952B2 (en) | Apparatus and method for dating a body sample | |
CA2347040C (en) | Method for non-invasive blood analyte measurement with improved optical interface | |
US5360004A (en) | Non-invasive determination of analyte concentration using non-continuous radiation | |
JP4071113B2 (en) | Noninvasive measurement of glucose by optical properties of tissue | |
JP3875798B2 (en) | Method of operating a bloodless measuring device for blood component concentration and bloodless measuring device | |
US7330747B2 (en) | Invasive chemometry | |
US20240268680A1 (en) | Time-of-flight sensors co-registered with camera systems | |
KR20180059355A (en) | Compact spectrometer system for non-invasive measurement of absorption and transmission spectra in biological tissue samples | |
US20060195021A1 (en) | Noninvasive blood analysis by optical probing of the veins under the tongue | |
JP2000037355A (en) | Method for measuring glucose concentration and apparatus therefor | |
WO2007072300A2 (en) | System for non-invasive measurement of blood glucose concentration | |
JPH02191434A (en) | Method and apparatus for near infrared quantitative analysis of blood sugar level | |
WO2003076883B1 (en) | Compact apparatus for noninvasive measurement of glucose through near-infrared spectroscopy | |
JP2001507457A (en) | Non-invasive infrared absorption spectrometer for temperature gradient spectra | |
JP2007083028A (en) | Noninvasive inspecting apparatus | |
WO2013134747A1 (en) | A combined absorption-reflection based instrument and technique to measure antioxidants (including carotenoids) in human tissue | |
CA3067312C (en) | System and method for noninvasive analysis of subcutaneous tissue | |
KR20050073854A (en) | Apparatus and method for measuring constituents of body | |
JP2004135798A (en) | Substance measuring instrument |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20191219 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20210208 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61B 5/1455 20060101ALI20210202BHEP Ipc: A61B 5/00 20060101AFI20210202BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20240424 |